Completed PHASE3 INTERVENTIONAL 2-arm NCT01052844

Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy

Clinical Trial of Gabapentin in the Prevention of Nausea Ond Vomiting Induced by Chemotherapy, a Randomized, Double-blind, Placebo Controled Study

Sponsor: Faculdade de Medicina do ABC

Conditions Cisplatin Adverse Reaction Vomiting

Interventions Gabapentin Placebo

Updated 5 times since 2017 Last updated: Jan 18, 2014 Started: Jan 31, 2009 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cisplatin Adverse Reaction and Vomiting and is currently completed. Faculdade de Medicina do ABC leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Faculdade de Medicina do ABC

Data source: Faculdade de Medicina do ABC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santo André, Brazil